Stocktoria
Axsome Therapeutics, Inc. AXSM
Axsome Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 3,299,991 | $265.6M | 6.49% |
| D. E. Shaw & Co., Inc. | 607,165 | $102.6M | 1.19% |
| Point72 Asset Management, L.P. | 424,750 | $71.8M | 0.83% |
| CITADEL ADVISORS LLC | 421,003 | $71.2M | 0.83% |
| TWO SIGMA INVESTMENTS, LP | 326,478 | $55.2M | 0.64% |
| RENAISSANCE TECHNOLOGIES LLC | 164,300 | $27.8M | 0.32% |
| AQR CAPITAL MANAGEMENT LLC | 104,059 | $17.6M | 0.2% |
| Bridgewater Associates, LP | 56,951 | $9.6M | 0.11% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.